INGN
Price
$8.47
Change
+$0.16 (+1.93%)
Updated
Dec 20, 04:59 PM (EDT)
72 days until earnings call
STRR
Price
$2.16
Change
-$0.04 (-1.82%)
Updated
Dec 20 closing price
Ad is loading...

INGN vs STRR

Header iconINGN vs STRR Comparison
Open Charts INGN vs STRRBanner chart's image
Inogen
Price$8.47
Change+$0.16 (+1.93%)
Volume$1.69K
CapitalizationN/A
Star Equity Holdings
Price$2.16
Change-$0.04 (-1.82%)
Volume$21.13K
CapitalizationN/A
INGN vs STRR Comparison Chart
Loading...
INGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
STRR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
INGN vs. STRR commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is INGN is a Hold and STRR is a Hold.

COMPARISON
Comparison
Dec 23, 2024
Stock price -- (INGN: $8.48 vs. STRR: $2.16)
Brand notoriety: INGN and STRR are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: INGN: 95% vs. STRR: 187%
Market capitalization -- INGN: $176.12M vs. STRR: $14.07M
INGN [@Medical Specialties] is valued at $176.12M. STRR’s [@Medical Specialties] market capitalization is $14.07M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.04B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

INGN’s FA Score shows that 0 FA rating(s) are green whileSTRR’s FA Score has 1 green FA rating(s).

  • INGN’s FA Score: 0 green, 5 red.
  • STRR’s FA Score: 1 green, 4 red.
According to our system of comparison, STRR is a better buy in the long-term than INGN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

INGN’s TA Score shows that 4 TA indicator(s) are bullish while STRR’s TA Score has 4 bullish TA indicator(s).

  • INGN’s TA Score: 4 bullish, 6 bearish.
  • STRR’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, STRR is a better buy in the short-term than INGN.

Price Growth

INGN (@Medical Specialties) experienced а -5.36% price change this week, while STRR (@Medical Specialties) price change was -17.75% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -1.51%. For the same industry, the average monthly price growth was +1.92%, and the average quarterly price growth was +0.64%.

Reported Earning Dates

INGN is expected to report earnings on Mar 04, 2025.

STRR is expected to report earnings on Aug 14, 2024.

Industries' Descriptions

@Medical Specialties (-1.51% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
INGN($176M) has a higher market cap than STRR($14.1M). INGN YTD gains are higher at: 54.463 vs. STRR (-58.660). STRR has higher annual earnings (EBITDA): -1.69M vs. INGN (-58.34M). INGN has more cash in the bank: 128M vs. STRR (23.2M). STRR has less debt than INGN: STRR (3.61M) vs INGN (21.9M). INGN has higher revenues than STRR: INGN (316M) vs STRR (45.8M).
INGNSTRRINGN / STRR
Capitalization176M14.1M1,248%
EBITDA-58.34M-1.69M3,458%
Gain YTD54.463-58.660-93%
P/E Ratio71.43N/A-
Revenue316M45.8M690%
Total Cash128M23.2M552%
Total Debt21.9M3.61M607%
FUNDAMENTALS RATINGS
INGN vs STRR: Fundamental Ratings
INGN
STRR
OUTLOOK RATING
1..100
6850
VALUATION
overvalued / fair valued / undervalued
1..100
79
Overvalued
98
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9594
PRICE GROWTH RATING
1..100
5894
P/E GROWTH RATING
1..100
651
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

INGN's Valuation (79) in the Medical Specialties industry is in the same range as STRR (98). This means that INGN’s stock grew similarly to STRR’s over the last 12 months.

INGN's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as STRR (100). This means that INGN’s stock grew similarly to STRR’s over the last 12 months.

STRR's SMR Rating (94) in the Medical Specialties industry is in the same range as INGN (95). This means that STRR’s stock grew similarly to INGN’s over the last 12 months.

INGN's Price Growth Rating (58) in the Medical Specialties industry is somewhat better than the same rating for STRR (94). This means that INGN’s stock grew somewhat faster than STRR’s over the last 12 months.

STRR's P/E Growth Rating (1) in the Medical Specialties industry is somewhat better than the same rating for INGN (65). This means that STRR’s stock grew somewhat faster than INGN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
INGNSTRR
RSI
ODDS (%)
Bullish Trend 3 days ago
72%
Bullish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 3 days ago
79%
Momentum
ODDS (%)
Bearish Trend 3 days ago
87%
N/A
MACD
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
87%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 3 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
86%
Advances
ODDS (%)
Bullish Trend 13 days ago
71%
Bullish Trend 13 days ago
78%
Declines
ODDS (%)
Bearish Trend 4 days ago
83%
Bearish Trend 3 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
73%
Bullish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 3 days ago
82%
Bearish Trend 3 days ago
85%
View a ticker or compare two or three
Ad is loading...
INGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
STRR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NXRT42.520.88
+2.11%
NexPoint Residential Trust
ERNA0.25N/A
+1.05%
Eterna Therapeutics
TER125.950.76
+0.61%
Teradyne
REZI24.510.12
+0.49%
Resideo Technologies
VSTM4.19-0.25
-5.63%
Verastem

INGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, INGN has been loosely correlated with VCYT. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if INGN jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INGN
1D Price
Change %
INGN100%
+2.05%
VCYT - INGN
42%
Loosely correlated
+4.66%
MYGN - INGN
35%
Loosely correlated
+1.44%
SHC - INGN
35%
Loosely correlated
-0.23%
ALC - INGN
31%
Poorly correlated
+0.69%
AVNS - INGN
31%
Poorly correlated
-2.78%
More

STRR and

Correlation & Price change

A.I.dvisor indicates that over the last year, STRR has been closely correlated with CATX. These tickers have moved in lockstep 88% of the time. This A.I.-generated data suggests there is a high statistical probability that if STRR jumps, then CATX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STRR
1D Price
Change %
STRR100%
-1.82%
CATX - STRR
88%
Closely correlated
+0.35%
NSYS - STRR
29%
Poorly correlated
+0.18%
INGN - STRR
23%
Poorly correlated
+2.05%
ELUT - STRR
23%
Poorly correlated
+37.11%
APYX - STRR
22%
Poorly correlated
+0.64%
More